BETAHISTINE-ZP betahistine dihydrochloride 16mg tablets blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

betahistine dihydrochloride, Quantity: 16 mg

Disponible desde:

Medis Pharma Pty Ltd

Designación común internacional (DCI):

betahistine dihydrochloride

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: crospovidone; lactose monohydrate; povidone; stearic acid; colloidal anhydrous silica; microcrystalline cellulose

Vía de administración:

Oral

Unidades en paquete:

100 tablets, 25 tablets, 10 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Resumen del producto:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B16 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2015-11-10